TÜKliF 1535: Translational strategies for the development of innovative molecular treatment approaches in medicine
The TÜKliF (1535) takes place at the Institute for Ophthalmic Research in seminar room 2.313 each Monday from 16:15 to 17:45.
| SPEAKER | TITLE | |
|---|---|---|
| 14.10.2024 | Marius Ueffing/Martin Elmlinger | Introduction:Challenges of translation in medicinal product development |
| 21.10.2024 | Martin Elmlinger | CANCELLED => Value chain from development to approved new medications |
| 28.10.2024 | Marius Ueffing | RD-Treat: Development program from basic research to translation - Part I |
| 04.11.2024 | Marius Ueffing | RD-Treat: Development program from basic research to translation - Part II |
| 11.11.2024 | Marius Ueffing | Diagnostics and biomarkers |
| 18.11.2024 | Francois Paquet-Durand | Qualifying protein kinase G as a drug target for the treatment of retinitis pigmentosa |
| 25.11.2024 | Guido Hanauer | Safety pharmacology and toxicology of candidate drugs |
| 02.12.2024 | Sven Schnichels | Proof-of-concept animal model studies in Ophthalmology |
| 09.12.2024 | Marius Ueffing/Martin Elmlinger | CANCELLED => Interactive exercise: Understanding the decision points of drug development |
| 16.12.2024 | Marius Ueffing/Martin Elmlinger | Interactive exercise: Understanding the decision points of drug development |
| 13.01.2025 | Martin Elmlinger | Clinical evidence of medical devices and in-vitro diagnostics |
| 20.01.2025 | Guido Hanauer, Martin Elmlinger | Aspects of ADME in drug development |
| 27.01.2025 | Mathias Seeliger | Biomarkers in the translation of preclinical research |
| 03.02.2025 | Martin Elmlinger | Biomarkers in precision medicine |
| 10.02.2025 | Test/Essay discussion | t.b.a. |